Literature DB >> 11114291

HHV8 associated Kaposi's sarcoma during triple immunosuppressive treatment with cyclosporin A, azathioprine, and prednisolone for ocular Behçet's disease and complete remission of both disorders with interferon alpha.

I Kötter1, C Aepinus, F Graepler, V Gärtner, A K Eckstein, N Stübiger, B Kaskas, M Zierhut, B Bültmann, R Kandolf, L Kanz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11114291      PMCID： PMC1753365          DOI： 10.1136/ard.60.1.83

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  6 in total

1.  [Myalgia in Neuro-Behçet's disease. Medication side effects or expression of underlying disease].

Authors:  M Krämer; M W Baumgärtel; E Neuen-Jacob; P Berlit
Journal:  Z Rheumatol       Date:  2008-05       Impact factor: 1.372

2.  Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis.

Authors:  I Kötter; M Zierhut; A K Eckstein; R Vonthein; T Ness; I Günaydin; B Grimbacher; S Blaschke; W Meyer-Riemann; H H Peter; N Stübiger
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

3.  [Ocular involvement in Behçet's disease: first 5-year-results for visual development after treatment with interferon alfa-2a].

Authors:  C M E Deuter; I Kötter; I Günaydin; M Zierhut; N Stübiger
Journal:  Ophthalmologe       Date:  2004-02       Impact factor: 1.059

Review 4.  Kaposi sarcoma in anti-neutrophil cytoplasmic antibody-associated vasculitis: a case-based review.

Authors:  Benedict K Tiong; Arun S Singh; G Peter Sarantopoulos; Tanaz A Kermani
Journal:  Rheumatol Int       Date:  2021-02-23       Impact factor: 2.631

5.  [Kaposi sarcoma complicating aplastic anemia].

Authors:  Mouna Lamchahab; Bouchra Oukkache; Sofia Marouan; Asmae Quessar; Said Benchekroun
Journal:  Pan Afr Med J       Date:  2014-06-19

6.  Morbidity of solid cancer in Behςet's disease: analysis of 11 cases in a series of 506 patients.

Authors:  So Young Na; Jaeyoung Shin; Eun-So Lee
Journal:  Yonsei Med J       Date:  2013-07       Impact factor: 2.759
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.